SCTX Scribe Therapeutics Inc.
$15.60▲ +1.27%
Healthcare
Other
Volume 348.5K
Avg Volume (10D) 403.6K
Key Metrics & Fundamentals
Market Cap
$295.33M
P/E Ratio
–
Div Yield
0.00%
52W Range
13.50 - 39.60
% vs 50 MA
-37.65%
% vs 200 MA
–%
RSI-14
34.5
MACD Histogram
-0.1400
Beta (1Y vs SPY)
-0.13
Free Cash Flow
-$5.35M
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
-$6.48M
Price & Volume History
Loading chart…
Recent News
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool · Oct 20, 2026 12:50 PM ET
What iShares Russell 2000 Index Fund (IWM) Bought: APNIMED Leads on Oct. 15
GuruFocus.com · Oct 19, 2026 7:03 AM ET
Cathie Wood Makes $64 Million Bet on Two Stocks
GuruFocus.com · Sep 28, 2026 3:11 PM ET
Beyond Meta, Cathie Wood’s ARKG Loads Up On These 4 Biotech Names
Stocktwits · Sep 22, 2026 7:10 AM ET
Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
Investor's Business Daily · Sep 17, 2026 4:09 PM ET
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire · Sep 2, 2026 4:05 PM ET
Scribe Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 8:00 AM ET
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls
The Fly · Aug 31, 2026 9:45 AM ET
Top Premarket Gainers
MT Newswires · Aug 24, 2026 7:13 AM ET
Norwegian Cruise downgrade, Duolingo upgraded: Wall Street's top analyst calls
The Fly · Aug 18, 2026 9:37 AM ET
Financial Overview - Income Statement
Quarterly
Mar 2026
See SCTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.